India Drug Makers Cede APIs To China To Focus On Finished Products
This article was originally published in PharmAsia News
Executive Summary
Aurobindo Pharma, Lupin, Ranbaxy Laboratories and Sun Pharma are among India's major makers of generic drugs that have ceded to China in recent years much of the market for active pharmaceutical ingredients.